Patient Guide: To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 88 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05365178
Status: ACTIVE_NOT_RECRUITING
Condition: HR-positive, HER2-negative Breast Neoplasms
Phase: PHASE3

Find a Study Location Near You

This study is available at 88 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Bengbu, Anhui
  • Wuhu, Anhui
  • Beijing, Beijing Municipality
  • • And 85 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily